Ethnicity and age related differences in treatment and control of dyslipidemia in hypertensive patients

Hendrix, Katharine H.; Riehle, Jessica; Egan, Brent M.

doi:10.1016/j.amjhyper.2004.03.523

Cited by 21 publications

(31 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…15 Treatment and risk factor control rates for hypertensive, dyslipidemic patients in primary care have been found to differ by patient gender and age. 5,16 Studies have also found demographic differences in the diagnosis and treatment of patients with CHD and angina. 13,[17][18][19][20][21] One analysis found gender to be an independent variable influencing primary care physician management of patients presenting for chest pain-with women receiving the fewest treatments and interventions.…”

Section: Gender-and Age-related Differences In Treatment and Control mentioning

confidence: 99%

“…[22][23][24] The importance of aggressively treating high cholesterol in young and middle-aged patients (especially those with multiple CV risk factors) is also clear. 6,16,25 Atherogenesis is a progressive disease, and cholesterol levels during young adulthood have been found to strongly predict the risk of CHD and related mortality in later years of life. 5 Furthermore, it has been found that the total cholesterol level in youth determines the age at which critical levels of atherosclerosis will be reached.…”

Section: Gender-and Age-related Differences In Treatment and Control mentioning

confidence: 99%

See 1 more Smart Citation

Gender‐ and Age‐Related Differences in Treatment and Control of Cardiovascular Risk Factors Among High‐Risk Patients With Angina

Hendrix

Mayhan

Egan

2005

J of Clinical Hypertension

View full text Add to dashboard Cite

were stratified by gender, age, and angina (n=2502) vs. nonangina (n=46,358) (angina, 43.94-43.96 vs. 34.42-34.50; nonangina, 32.43-32.43 vs. 17.25-17.25) and 100-129 mg/dL (angina, 32.12-32.14 vs. 35.10-35.18; nonangina, 53.86-53.86 vs. 32.44-32.44). More women than men had LDL-C ≥130 mg/dL (angina, 27.68-27.72 vs. 23.91-23.93; nonangina, 38.70-38.70 vs. 35.38-35.39). Women were less likely than men to receive statins (angina, 69.95-69.99 vs. 82.11-82.13; nonangina, 59.80-59.80 vs. 63.72-63.72), any antilipidemic medication at all (angina, 25.93-25.97 vs. 13.48-13.48; nonangina, 36.73-36.73 vs. 30.73-30.73), or to have current cholesterol measurements (angina, 56.82-56.88 vs. 34.54-34.56; nonangina, 45.77-45.77 vs. 39.75-39.75 C oronary heart disease (CHD) is the single leading cause of death in both men and women in the United States, accounting for more than one out of every five deaths in 2001.1 Hypertension is one of the most significant risk factors for development of CHD, affecting over half of all people who have suffered a first heart attack, and preceding development of congestive heart failure in 91% of cases. 2,3 While the health problems presented by CHD and hypertension have long been recognized in men and older patients, the magnitude of the burden of these diseases in women and younger patients has been largely overlooked until recent decades.4-6 While women do have some health advantages over men regarding the development of heart disease, these advantages are demonstrably not universal-and once CHD is manifest, women lose prognostic superiority over men. 7,8 Elevated low-density lipoprotein cholesterol (LDL-C) levels (dyslipidemia) are well documented as a major contributor to the development of atherosclerosis and subsequent coronary disease. 9Hypertensive patients with dyslipidemia are at increased risk for formation of atherosclerotic

show abstract

Section: Gender-and Age-related Differences In Treatment and Control mentioning

confidence: 99%

Section: Gender-and Age-related Differences In Treatment and Control mentioning

confidence: 99%

Gender‐ and Age‐Related Differences in Treatment and Control of Cardiovascular Risk Factors Among High‐Risk Patients With Angina

Hendrix

Mayhan

Egan

2005

J of Clinical Hypertension

View full text Add to dashboard Cite

show abstract

“…Physicians are essentially not prescribing statins to those who qualify for them. For example, in one study (10), 72,351 hypertensive patients were analyzed for the presence of hyperlipidemia and their cholesterol management. Of these patients, 38,116 were found to be dyslipidemic.…”

Section: Narrowing the Treatment Gapmentioning

confidence: 99%

Should cholesterol-lowering medications be available in Canada without a prescription?

Rashid

2007

Canadian Journal of Cardiology

View full text Add to dashboard Cite

“…[2][3][4][5] There is further evidence that minority women may be less likely to receive appropriate treatment than white women even when access to care is similar or identical. [6][7][8][9][10] We conducted the following study to assess healthcare providers' baseline knowledge of CVD and to determine the effects of a structured educational program on provider knowledge and self-assessed skills.…”

Section: Introductionmentioning

confidence: 99%

The Heart Truth Professional Education Campaign on Women and Heart Disease: Needs Assessment and Evaluation Results

Pregler

Freund

Kleinman

et al. 2009

Journal of Women's Health

View full text Add to dashboard Cite

Background: Heart disease is the leading cause of death for women in the United States. Research has identified that women are less likely than men to receive medical interventions for the prevention and treatment of heart disease. Methods and Results: As part of a campaign to educate healthcare professionals, 1245 healthcare professionals in 11 states attended a structured 1-hour continuing medical education (CME) program based on the 2004 AHA Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women and completed a pretest and posttest evaluation. We identified significant knowledge deficits in the pretest: 45% of attendees would initially recommend lifestyle changes alone, rather than statin therapy, for women diagnosed with coronary artery disease (CAD); 38% identified statin therapy as less effective in women compared with men for preventing CAD events; 27% identified Asian American women at low risk (rather than high risk) for type 2 diabetes mellitus (DM); and 21% identified processed meat (rather than baked goods) as the principal dietary source of trans fatty acids. Overall, healthcare professionals answered 5.1 of 8 knowledge questions correctly in the pretest, improving to 6.8 questions in the posttest ( p < 0.001). Family physicians, obstetrician=gynecologists, general internists, nurse practitioners=physician assistants, and registered nurses all statistically significantly improved knowledge and self-assessed skills and attitudes as measured by the posttest. Conclusions: Significant knowledge deficits are apparent in a cross-section of healthcare providers attending a CME lecture on women and heart disease. A 1-hour presentation was successful in improving knowledge and self-assessed skills and attitudes among primary care physicians, nurse practitioners, physician assistants, and registered nurses.

show abstract

Ethnicity and age related differences in treatment and control of dyslipidemia in hypertensive patients

Cited by 21 publications

References 0 publications

Gender‐ and Age‐Related Differences in Treatment and Control of Cardiovascular Risk Factors Among High‐Risk Patients With Angina

Gender‐ and Age‐Related Differences in Treatment and Control of Cardiovascular Risk Factors Among High‐Risk Patients With Angina

Should cholesterol-lowering medications be available in Canada without a prescription?

The Heart Truth Professional Education Campaign on Women and Heart Disease: Needs Assessment and Evaluation Results

Contact Info

Product

Resources

About